A decision aid for women at increased risk for ovarian cancer

被引:12
作者
Tiller, K [1 ]
Meiser, B
Reeson, E
Tucker, M
Andrews, L
Gaff, C
Kirk, J
Phillips, KA
Friedlander, M
机构
[1] Prince Wales Hosp, Hereditary Canc Clin, Randwick, NSW 2031, Australia
[2] Royal N Shore Hosp, Dept Psychol Med, Sydney, NSW, Australia
[3] Royal N Shore Hosp, NSW Genet Educ Program, Sydney, NSW, Australia
[4] Genet Hlth Serv, Melbourne, Vic, Australia
[5] Royal Melbourne Hosp, Familial Canc Ctr, Melbourne, Vic, Australia
[6] Westmead Hosp, Familial Canc Serv, Sydney, NSW, Australia
[7] Peter MacCallum Canc Inst, Div Haematol & Med Oncol, Melbourne, Vic 3000, Australia
[8] Peter MacCallum Canc Inst, Familial Canc Ctr, Melbourne, Vic 3000, Australia
[9] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia
关键词
decision aids; hereditary ovarian cancer; risk management options;
D O I
10.1046/j.1525-1438.2003.13018.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This paper reviews changes that have occurred within and without the medical profession that have fostered an increasing demand for decision aids as adjuncts to practitioners' counseling to prepare patients for decision making. In the absence of data on the efficacy of ovarian cancer screening and prophylactic strategies, decisions about optimal care are difficult for both women and their doctors. Because surveillance and preventive options are an area of great uncertainty, a decision aid has been developed specifically aimed at facilitating decisions involving ovarian cancer risk management options. This was achieved by reviewing and integrating the available literature on models of medical decision making, patient preferences for information and involvement in decision making, the utility of decision aids, and management options for ovarian cancer risk. Findings indicate that patients wish to be informed participants in the decision-making process and that decision aids are an acceptable and effective method of providing quality information in a format that facilitates an inclusive model of shared decision making. A decision aid designed for women at increased risk of ovarian cancer that facilitates informed decision making may be a valuable addition to patient support. A randomized controlled trial of this type of educational material will provide timely and much needed evidence on its acceptability and efficacy.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 76 条
[61]  
2-#
[62]   FAMILIAL OVARIAN-CANCER - A POPULATION-BASED CASE-CONTROL STUDY [J].
SCHILDKRAUT, JM ;
THOMPSON, WD .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 128 (03) :456-466
[63]   Evaluation of a shared decision making program for women suspected to have a genetic predisposition to breast cancer: Preliminary results [J].
Stalmeier, PFM ;
Unic, IJ ;
Verhoef, LCG ;
Van Daal, WAJ .
MEDICAL DECISION MAKING, 1999, 19 (03) :230-241
[64]   Information needs and decisional preferences among women with ovarian cancer [J].
Stewart, DE ;
Wong, F ;
Cheung, AM ;
Dancey, J ;
Meana, M ;
Cameron, JI ;
McAndrews, MP ;
Bunston, T ;
Murphy, J ;
Rosen, B .
GYNECOLOGIC ONCOLOGY, 2000, 77 (03) :357-361
[65]   DO PATIENTS WANT TO PARTICIPATE IN MEDICAL DECISION-MAKING [J].
STRULL, WM ;
LO, B ;
CHARLES, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (21) :2990-2994
[66]   Variation in cancer risks, by mutation position, in BRCA2 mutation carriers [J].
Thompson, D ;
Easton, D .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (02) :410-419
[67]  
TOBACMAN JK, 1982, LANCET, V2, P795
[68]   The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer [J].
van Nagell, JR ;
Depriest, PD ;
Reedy, MB ;
Gallion, HH ;
Ueland, FR ;
Pavlik, EJ ;
Kryscio, RJ .
GYNECOLOGIC ONCOLOGY, 2000, 77 (03) :350-356
[69]   Current policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics [J].
Vasen, HFA ;
Haites, NE ;
Evans, DGR ;
Steel, CM ;
Moller, P ;
Hodgson, S ;
Eccles, D ;
Morrison, P ;
Lyonet, DS ;
Chang-Claude, J ;
Caligo, M .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) :1922-1926
[70]   Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis [J].
Vasen, HFA ;
Wijnen, JT ;
Menko, FH ;
Kleibeuker, JH ;
Taal, BG ;
Griffioen, G ;
Nagengast, FM ;
MeijersHeijboer, EH ;
Bertario, L ;
Varesco, L ;
Bisgaard, ML ;
Mohr, J ;
Fodde, R ;
Khan, PM .
GASTROENTEROLOGY, 1996, 110 (04) :1020-1027